HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gül Atilla Selected Research

Alveolar Bone Loss

10/2009Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats.
1/2007Matrix Metalloproteinases, Tissue Inhibitor of Matrix Metalloproteinase-1, and Laminin-5 γ2 Chain Immunolocalization in Gingival Tissue of Endotoxin-Induced Periodontitis in Rats: Effects of Low-Dose Doxycycline and Alendronate.
1/2007Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
5/2006Dietary Supplementation of Omega-3 Fatty Acid and Circulating Levels of Interleukin-1β, Osteocalcin, and C-Reactive Protein in Rats.
5/2006Dietary supplementation of omega-3 fatty acid and circulating levels of interleukin-1beta, osteocalcin, and C-reactive protein in rats.
11/2005Systemic low-dose doxycycline and alendronate administration and serum interleukin-1beta, osteocalcin, and C-reactive protein levels in rats.
12/2004Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats.
11/2004Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gül Atilla Research Topics

Disease

25Periodontitis
11/2017 - 03/2004
24Chronic Periodontitis
05/2020 - 01/2002
20Gingivitis
05/2020 - 04/2003
16Periodontal Diseases (Periodontal Disease)
11/2017 - 01/2004
15Aggressive Periodontitis (Periodontosis)
04/2017 - 03/2004
14Gingival Overgrowth
12/2016 - 04/2003
11Inflammation (Inflammations)
09/2016 - 04/2003
8Alveolar Bone Loss
10/2009 - 11/2004
5Bone Resorption
05/2007 - 11/2004
3Hemorrhage
06/2011 - 10/2004
2Fibrosis (Cirrhosis)
12/2016 - 09/2015
2Hypertension (High Blood Pressure)
07/2014 - 02/2008
2Periodontal Pocket (Periodontal Pockets)
07/2006 - 10/2004
1Gingival Recession
11/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2016
1Calculi (Calculus)
06/2011
1Myocardial Infarction
05/2011

Drug/Important Bio-Agent (IBA)

14Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2016 - 04/2003
11Matrix Metalloproteinases (MMPs)IBA
08/2014 - 06/2002
8Doxycycline (Periostat)FDA LinkGeneric
03/2011 - 01/2004
8LipopolysaccharidesIBA
10/2009 - 12/2004
8Escherichia coli endotoxinIBA
10/2008 - 11/2004
7Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
10/2008 - 12/2004
6OsteocalcinIBA
10/2011 - 11/2005
5Tissue Inhibitor of Metalloproteinase-1IBA
08/2014 - 12/2006
5EndotoxinsIBA
01/2007 - 11/2004
5C-Reactive ProteinIBA
05/2006 - 11/2005
4CytokinesIBA
09/2015 - 11/2006
4Interleukin-6 (Interleukin 6)IBA
09/2015 - 11/2006
4Tacrolimus (Prograf)FDA LinkGeneric
03/2015 - 03/2008
4Pharmaceutical PreparationsIBA
03/2014 - 04/2003
4DNA (Deoxyribonucleic Acid)IBA
06/2011 - 04/2006
4Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
05/2011 - 01/2002
4Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2008 - 01/2005
4Celecoxib (Celebrex)FDA Link
10/2008 - 01/2005
4Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
10/2008 - 01/2007
4Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2007 - 11/2004
4KalininIBA
01/2007 - 10/2004
3Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
08/2016 - 12/2006
3OsteoprotegerinIBA
05/2011 - 05/2007
3Tissue Plasminogen Activator (Alteplase)FDA Link
05/2010 - 04/2007
3Plasminogen Activators (Plasminogen Activator)IBA
05/2010 - 04/2007
3InterleukinsIBA
10/2009 - 04/2006
3Interleukin-1beta (Interleukin 1 beta)IBA
05/2006 - 11/2005
2Antimicrobial PeptidesIBA
04/2017 - 03/2015
2Chemokine CCL5IBA
09/2016 - 10/2004
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2016 - 10/2004
2Proteins (Proteins, Gene)FDA Link
09/2016 - 05/2011
2EnzymesIBA
07/2014 - 01/2014
2Peroxidase (Myeloperoxidase)IBA
07/2014 - 10/2010
2ChlorhexidineIBA
05/2014 - 06/2011
2Biomarkers (Surrogate Marker)IBA
10/2012 - 05/2011
2CathelicidinsIBA
06/2011 - 06/2009
2Tuberculin (PPD)IBA
06/2011 - 09/2006
2LigandsIBA
05/2011 - 05/2007
2Peptides (Polypeptides)IBA
02/2010 - 08/2005
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2009 - 03/2009
2AngiotensinogenIBA
04/2009 - 03/2009
2Transforming Growth Factor beta1 (TGF beta 1)IBA
08/2008 - 09/2006
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2008 - 12/2007
2Plasminogen Activator Inhibitor 1IBA
07/2007 - 04/2007
2Peptide Hydrolases (Proteases)FDA Link
07/2006 - 04/2006
2Fatty Acids (Saturated Fatty Acids)IBA
05/2006 - 05/2006
2Diphosphonates (Bisphosphonates)IBA
11/2005 - 11/2004
2Proteoglycans (Proteoglycan)IBA
06/2005 - 03/2004
2DinoprostIBA
01/2005 - 12/2004
2Leukotriene B4IBA
01/2005 - 12/2004
2Platelet Activating FactorIBA
01/2005 - 12/2004
2Dinoprostone (PGE2)FDA Link
01/2005 - 12/2004
1Oxidants (Oxidizing Agents)IBA
11/2017
1Thiobarbituric Acid Reactive SubstancesIBA
11/2017
1AntioxidantsIBA
11/2017
1TransglutaminasesIBA
12/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2016
1Sodium Glutamate (Accent)IBA
09/2016
1Melanocyte-Stimulating Hormones (MSH)IBA
09/2016
1Macrophage Migration-Inhibitory FactorsIBA
09/2016
1Triglycerides (Triacylglycerol)IBA
09/2016
1Glucose (Dextrose)FDA LinkGeneric
09/2016
1Metalloproteases (Metalloproteinases)IBA
08/2016
1Cyclophilin AIBA
08/2016
1Leukocyte Elastase (Neutrophil Elastase)IBA
07/2014
1IntegrinsIBA
03/2014
1Collagen Type I (Type I Collagen)IBA
03/2014
1Cathepsin CIBA
01/2014
1Myeloblastin (Proteinase 3)IBA
01/2014
1Azithromycin (Zithromax)FDA LinkGeneric
12/2012
1Oncostatin MIBA
10/2012
1Leukemia Inhibitory FactorIBA
10/2012
1Interleukin-11 (Interleukin 11)IBA
10/2012
1Leukocyte L1 Antigen Complex (Calgranulin)IBA
10/2011
1Toll-Like Receptor 4IBA
05/2011
1ChemokinesIBA
03/2011
1ProstaglandinsIBA
05/2010
1Prostaglandins EIBA
05/2010

Therapy/Procedure

13Therapeutics
08/2014 - 01/2002
4Root Planing
03/2011 - 01/2002
3Oral Hygiene (Dental Hygiene)
05/2020 - 06/2005
3Aftercare (After-Treatment)
11/2016 - 03/2004
2Injections
05/2006 - 05/2006